The association of high FAM210B levels with upregulated androgen response, fatty acid metabolism, and downregulated EMT and inflammatory response pathways highlights its potential role in modulating tumour biology through metabolic reprogramming and immune evasion mechanisms. The gene discussed is MIMS2; the disease is neoplasm.